Sparrow Therapy System

FDA 510(k) K201873 · Spark Biomedical, Inc.

Substantially Equivalent

510(k) numberK201873

Submission

Device name
Sparrow Therapy System
Applicant
Spark Biomedical, Inc.
Dallas, TX, US
Received
July 7, 2020
Decision date
January 2, 2021
Decision
Substantially Equivalent (SESE)
Type
Traditional 510(k)
Summary
510(k) summary available from FDA

Official FDA 510(k) record

Device classification

Product code
PZR – Percutaneous Nerve Stimulator For Opioid Withdrawal
Device class
Class II (moderate risk)
Regulation
21 CFR 882.5896
Specialty
Neurology

Stimulate nerve branches to aid in the reduction of symptoms associated with substance use disorders.

Other 510(k)s with product code PZR

510(k)DeviceApplicantDecision
K251246Sparrow AscentPZR · Traditional Spark Biomedical, Inc.08/25/2025SE
K233166NET Recovery Corp/NET DevicePZR · Traditional Net Recovery05/29/2024SE
K230796Sparrow AscentPZR · Traditional Spark Biomedical, Inc.06/20/2023SE
K221231Drug Relief v1PZR · Special Dyansys, Inc.06/06/2022SE
K211971Drug Relief v1PZR · Traditional Dyansys, Inc.11/05/2021SE
K173861Drug ReliefPZR · Traditional Dyansys, Inc.05/02/2018SE

More from Dyansys, Inc.

510(k)DeviceDecision
K251246Sparrow AscentPZR · Traditional 08/25/2025SE
K230796Sparrow AscentPZR · Traditional 06/20/2023SE

Questions and answers

When was Sparrow Therapy System cleared by the FDA?

Sparrow Therapy System (K201873) received a 510(k) decision of Substantially Equivalent on January 2, 2021, 179 days after the submission was received.

What is the product code of K201873?

The FDA product code is PZR – Percutaneous Nerve Stimulator For Opioid Withdrawal, a Class II (moderate risk) device regulated under 21 CFR 882.5896.